ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer | The Uromigos | lystn | Audio Stories, Podcasts, Originals

ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer

Neeraj Agarwal describes the results of this positive randomised Phase 3 trial.

2356 232

ASCO GU 2024: CONTACT2 - Cabozantinib and Atezolizumab in Prostate Cancer3 months ago

31:15

Suggested Podcasts

The Great Outdoors Photography Podcast

The HeyCreator Show

Wharton Business Daily

Can't Bowl Can't Throw Cricket Show

Handbrake Off - A show about Arsenal

Robb Wolf - The Paleo Solution Podcast - Paleo diet, nutrition, fitness, and health

PROFIT AND BEAUTY: A Show For Salon Professionals

Hustle & Flow

Women 4 LULAC

Bhay Originals

Download the app

Get it on Google Play Available on the App Store

PRIVACY POLICY | TERMS AND CONDITIONS

lystn.fm © 2024.
ALL RIGHTS RESERVED. CONTENT IS COPYRIGHT OF RESPECTIVE CONTENT OWNERS. | NX Digital FZ LLC & Tellyfonic Digital Media